The Uromigos Episode 157: ASCO GU 2022 Sacituzumab and Pembrolizumab in Bladder Cancer
By The Uromigos - Last Updated: February 18, 2022Dr Petros Grivas describes the results of the phase 2 trial of sacituzumab and pembrolizumab in bladder cancer presented at the 2022 ASCO GU Symposium.
Post Tags:Uromigos-ASCO GU
Did you like this article?
670 Madison Ave.
Manalapan, NJ 07726
© 2022 Mashup Media, LLC. All rights reserved.